Corrigendum: Targeting myeloid checkpoint molecules in combination with antibody therapy: A novel anti-cancer strategy with IgA antibodies?

• Chilam Chan,
• Marta Lustig,
• Niklas Baumann,
• Thomas Valerius,
• Geert van Tetering,
• Jeanette H. W. Leusen

Affiliations

Chilam Chan

Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands

Marta Lustig

Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Niklas Baumann

Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Thomas Valerius

Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Geert van Tetering

Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands

Jeanette H. W. Leusen

Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands